Human Genome Sciences Inc. (Nasdaq: HGSI) CEO, Thomas Watkins, bought 20,000 shares on 3/11 at $4.93-$4.94 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE